Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation

Archives of Ophthalmology

Volumn 124, Issue 4, 2006, Pages 487-492

  Freund, K Bailey ^a   Klais, Christina M ^a   Eandi, Chiara M ^a   Ober, Michael D ^a   Goldberg, Daniel E ^a   Sorenson, John A ^a   Yannuzzi, Lawrence A ^a  

^a EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EYE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; INDOCYANINE GREEN ANGIOGRAPHY; INJECTION; INTRAOCULAR HYPERTENSION; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETINA EXUDATE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA NEOVASCULARIZATION; RETINAL ANGIOMATOUS PROLIFERATION; SCIENCE; STANDARD; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; ANGIOMATOSIS; COLORING AGENTS; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INDOCYANINE GREEN; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; PROSPECTIVE STUDIES; RECURRENCE; RETINAL NEOVASCULARIZATION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33645863754     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.4.487     Document Type: Article

References (39)

1. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416-434.
2. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol. 1995;113:1392-1398.
3. Lafaut BA, Aisenbrey S, Broecke CV, Bartz-Schmidt KU. Clinicopathological correlation of deep retinal vascular anomalous complex in age-related macular degeneration. Br J Ophthalmol. 2000;84:1269-1274.
4. Bermig J, Tylla H, Jochmann C, Nestler A, Wolf S. Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002;240:169-175.
5. Gross NE. The natural course of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation [abstract]. Invest Ophthalmol Vis Sci. 2004;45:S127.
6. Brucker AJ, Aizman A, Gross NE, Yannuzzi LA. The characteristics of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation [abstract]. Invest Ophthalmol Vis Sci. 2004;45:S129.
7. Silva RM, Faria de Abreu JR, Travassos A, Cunha-Vaz JG. Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomosis. Graefes Arch Clin Exp Ophthalmol. 2004;242:368-376.
8. Axer-Siegel R, Ehrlich R, Rosenblatt I, et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol. 2004;122:453-459.
9. Axer-Siegel R, Bourla D, Priel E, Yassur Y, Weinberg D. Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization. Ophthalmology. 2002;109:1726-1736.
10. Hartnett ME, Weiter JJ, Staurenghi G, Eisner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology. 1996;103:2042-2053.
11. Da Pozzo S, Battaglia Parodi M, Ravalico G. A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration. Int Ophthalmol. 2001;24:187-194.
12. Kuroiwa S, Arai J, Gaun S, Iida T, Yoshimura N. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina. 2003;23:417-420.
13. Borrillo JL, Sivalingam A, Mrtidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol. 2003;121:558-561.
14. Yannuzzi LA, Klancnik J, Gross N, et al. Retinal angiomatous proliferation (RAP): treatment with anecortave acetate. Paper presented at: 26th Annual Macula Society Meeting; February 27, 2003; Naples, Fla.
15. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2003;110:1517-1525.
16. Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye. 1990;4:613-621.
17. Dastgheib K, Green WR. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 1994;112:813-818.
18. Schmidt-Erfurth U, Schlötzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2003;44:4473-4480.
19. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-560.
20. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol. 2001;119:198-207.
21. Campochiaro PA, Soloway P, Ryan SJ, Miller JW. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis. 1999;5:34.
22. Heckenlively JR, Hawes NL, Friedlander M, et al. Mouse model of subretinal neo-vascularization with choroidal anastomosis. Retina. 2003;23:518-522.
23. Okamoto N, Tobe T, Hackett SF, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997;151:281-291.
24. Slakter JS, Yannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult neovascularization in age-related macular degeneration. Ophthalmology. 2000;107:742-754.
25. Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol. 2004;138:1077-1079.
26. Penfold PL, Wen L, Madigan MC, et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol. 2000;121:458-465.
27. Penfold PL, Wen L, Madigan MC, et al. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci. 2002;43:3125-3130.
28. Hori Y, Hu DE, Yasui K, et al. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br J Pharmacol. 1996;118:1584-1591.
29. Halaby IA, Lydeen SP, Davies MG, et al. Glucocorticoid-regulated VEGF expression in ischemic skeletal muscle. Mol Ther. 2002;5:300-306.
30. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992;110:1155-1159.
31. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891-1898.
32. Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: a pilot study. Aust N Z J Ophthalmol. 1995;23:293-298.
33. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 months follow up. Aust N Z J Ophthalmol. 1998;26:277-281.
34. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244-250.
35. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol. 1999;117:1329-1345.
36. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;121:57-61.
37. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004;122:1131-1136.
38. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after single intravitreal injection. Ophthalmology. 2003;110:681-686.
39. Schmidt-Erfurth U, Hasan T. Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol. 2000;45:195-214.